G. Engel - Concepedia

Author

G. Engel

Novartis (Switzerland)

Also Known As

G ENGEL, G Engel, G. Engel, Gunter Engel, Günter Engel

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Psychiatry Baselland Max Planck Institute of Experimental Medicine Goethe University Frankfurt

About

G. Engel is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	3.8K
2	Social Sciences	8	8	1.3K
3	Health Sciences	4	4	367
4	Natural Sciences	4	4	78
5	Engineering	2	2	97

G. Engel

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine Philip Bradley, G. Engel, W. Feniuk, Neuropharmacology Medicinal ChemistryFunctional ReceptorsFunctional SelectivityMedicinePhysiology	1986	1.3K
Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: Radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]Ketanserin Daniël Hoyer, G. Engel, Hans O. Kalkman European Journal of Pharmacology Molecular PharmacologyPig Brain MembranesMolecular NeuroscienceMolecular PhysiologyBiochemistry	1985	577
The pharmacology and function of 5-HT3receptors B. P. Richardson, G. Engel Trends in Neurosciences Molecular PharmacologySignal TransductionMolecular PhysiologyMedicinePhysiology	1986	385
Characterization of the 5-HTIB recognition site in rat brain: Binding studies with (−)[125I]Iodocyanopindolol Daniël Hoyer, G. Engel, Hans O. Kalkman European Journal of Pharmacology Neuroimaging BiomarkersNeurophysiologyCellular NeuroscienceNeuropharmacologyBrain Science	1985	281
The β-adrenergic receptor in human lymphocytes: Subclassification by the use of a new radio-ligand, (±)−125iodocyanopindolol Otto‐Erich Brodde, G. Engel, Daniël Hoyer, Life Sciences Molecular PharmacologyNew Radio-ligandHuman LymphocytesSignal TransductionAdrenal Gland	1981	208
Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves G. Engel, M. G�thert, Else M�ller-Schweinitzer, Naunyn-Schmiedeberg s Archives of Pharmacology NeurophysiologyMedicineSympathetic Nervous SystemPhysiologySympathetic Nerves	1983	203
5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus R. Markstein, Daniël Hoyer, G. Engel Naunyn-Schmiedeberg s Archives of Pharmacology Rat HippocampusMolecular PharmacologyMolecular PhysiologyNeurophysiologyFunctional Selectivity	1986	199
β-Adrenoceptor blocking agents recognize a subpopulation of serotonin receptors in brain Ángel Pazos, G. Engel, José Palacios Brain Research NeurophysiologyMedicineNeurotransmitterNeuroendocrine MechanismNeuropeptide Receptor	1985	115
Affinity spectra: A novel way for the evaluation of equilibrium binding experiments Hans-Jakob Tobler, G. Engel Naunyn-Schmiedeberg s Archives of Pharmacology Equilibrium Binding ExperimentsEngineeringBiochemistryMedicineMolecular Biology	1983	83
5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205–930 in the guinea-pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in-vivo K H Buchheitt, B. Costall, G. Engel, Journal of Pharmacy and Pharmacology Gastrointestinal PharmacologyGastroenterologyPharmacotherapyGuinea-pig StomachExperimental Pharmacology	1985	83

Page 1